NPM1 and acute myeloid leukemia: NPM1 mutation occurs in approximately 35% of all cases and up to 60% of patients with normal karyotype AML [7,11] and prognostic implications are mediated by presence of other mutations including FLT3-internal tandem duplication (FLT3-ITD).